Seeing Is Believing

Currently out of the existing stock ratings of Karen Koski, 7 are a HOLD (43.75%), 1 are a SELL (6.25%), 8 are a BUY (50%).
Analyst Karen Koski, carries an average stock price target met ratio of 93.33% that have a potential upside of 47.34% achieved within 416 days. Previously, Karen Koski worked at BTIG.
Karen Koski’s has documented 28 price targets and ratings displayed on 7 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AXDX, Accelerate Diagnostics at 08-Oct-2020.
Analyst best performing recommendations are on OSUR (ORASURE TECHNOLOGIES).
The best stock recommendation documented was for AXDX (ACCELERATE DIAGNOSTICS) at 8/9/2016. The price target of $260 was fulfilled within 36 days with a profit of $40 (18.18%) receiving and performance score of 5.05.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$5
$3.92 (362.96%)
$3
2 years 2 months 23 days ago
(30-Jul-2024)
6/6 (100%)
$0.11 (2.25%)
16
Hold
3 years 2 months 8 days ago
(15-Aug-2023)
3/4 (75%)
$-3.75 (-34.88%)
38
Hold
$7500
4 years 3 months 16 days ago
(07-Jul-2022)
3/5 (60%)
$3649 (94.75%)
390
Buy
$15000
5 years 11 months 18 days ago
(05-Nov-2020)
1/1 (100%)
$7050 (88.68%)
177
Hold
$200
$194.55 (3569.72%)
$200
9 years 5 months 16 days ago
(08-May-2017)
2/3 (66.67%)
$64.67 (8.94%)
172